NCT00540215View on ClinicalTrials.gov

GLP-2 (Glucagonlike Peptide-2) and Blood Flow

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

January 31, 2008

Study Completion Date

February 29, 2008

Conditions
Regional Blood Flow
Interventions
OTHER

Glucagonlike peptide

450 nmol native form, synthetic

Trial Locations (1)

2600

Glostrup University Hospital, Glostrup Municipality

All Listed Sponsors
lead

Glostrup University Hospital, Copenhagen

OTHER

NCT00540215 - GLP-2 (Glucagonlike Peptide-2) and Blood Flow | Biotech Hunter | Biotech Hunter